SNSE

Faeth Therapeutics, Inc. · HEALTHCARE

Insiders bought $1.3M of Faeth Therapeutics, Inc. in the last 12 months

1 insider bought on 3 days.

$1.3MBought, 12 mo

$2.1MSold, 12 mo

$18.6MMarket cap

Follow SNSE

SNSE over the last year

Insider buy filed (1 day)

Largest buyers, last 12 months

Millennium Management LLC10% owner · 3 days$1.3M

SNSE after insider buys

3 months after each buy, from the first price a copier could get.

1 buy has 3 months of prices so far. A record shows here at 3.

Every filing

63 insider filings since 2021, newest first

SNSESell

Cambrian BioPharma Inc · 10% owner

$501K−16.1%Jun 1

SNSESell

James Peyer · Insider

$501K−16.1%Jun 1

SNSESell

MILLENNIUM MANAGEMENT LLC · 10% owner

$538K−11.3%May 15

SNSEBuy

Millennium Management LLC · 10% owner

$141K+3.0%May 15

SNSEBuy

Millennium Management LLC · 10% owner

$382K+9.0%May 15

SNSEBuy

MILLENNIUM MANAGEMENT LLC · 10% owner

$818K+26.6%May 15

SNSESell

Cambrian Biopharma Inc · 10% owner

$55K−4.0%Dec 10

SNSESell

James Peyer · 10% owner

$55K−4.0%Dec 10

SNSESell

Cambrian Biopharma Inc · 10% owner

$233K−12.0%Dec 8

SNSESell

James Peyer · 10% owner

$233K−12.0%Dec 8

SNSESell

Apeiron Investment Group Ltd. · 10% owner

$5.4M−100.0%Jun 2

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$136KApr 21

SNSEBuy

James Peyer · Director and 10% owner

$136KApr 21

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$64KFeb 24

SNSEBuy

James Peyer · Director and 10% owner

$64KFeb 24

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$80KFeb 22

SNSEBuy

James Peyer · Director and 10% owner

$80KFeb 22

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$53KFeb 16

SNSEBuy

James Peyer · Director and 10% owner

$53KFeb 16

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$78KFeb 14

SNSEBuy

James Peyer · Director and 10% owner

$78KFeb 14

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$136K+1.0%Feb 8

SNSEBuy

James Peyer · Director and 10% owner

$136K+1.0%Feb 8

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$64KJan 31

SNSEBuy

James Peyer · Director and 10% owner

$64KJan 31

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$236K+1.0%Jan 27

SNSEBuy

James Peyer · Director and 10% owner

$236K+1.0%Jan 27

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$229K+1.0%Jan 25

SNSEBuy

James Peyer · Director and 10% owner

$229K+1.0%Jan 25

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$154K+1.0%Jan 21

SNSEBuy

James Peyer · Director and 10% owner

$154K+1.0%Jan 21

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$51KJan 20

SNSEBuy

James Peyer · Director and 10% owner

$51KJan 20

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$133K+1.0%Jan 18

SNSEBuy

James Peyer · Director and 10% owner

$133K+1.0%Jan 18

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$104KJan 13

SNSEBuy

James Peyer · Director and 10% owner

$104KJan 13

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$53KJan 11

SNSEBuy

James Peyer · Director and 10% owner

$53KJan 11

SNSESell

Robert Hamilton Pierce · Chief Scientific Officer

$118K−100.0%Aug 12

SNSESell

Robert Hamilton Pierce · Chief Scientific Officer

$568K−83.0%Aug 10

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$26KApr 20

SNSEBuy

James Peyer · Director and 10% owner

$26KApr 20

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$28KApr 14

SNSEBuy

James Peyer · Director and 10% owner

$28KApr 14

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$28KApr 8

SNSEBuy

James Peyer · Director and 10% owner

$28KApr 8

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$53KMar 25

SNSEBuy

James Peyer · Director and 10% owner

$53KMar 25

SNSEBuy

Cambrian Biopharma Inc · 10% owner

$143KMar 24

Older filings

Filings come from SEC EDGAR and prices from daily closes. Not investment advice.